Metraipolis › archive › dc_7e2506e83022

Nivolumab and Ipilimumab in Advanced Mismatch Repair-Deficient/Microsatellite Instability-High Noncolorectal Cancers: A Nonrandomized Clinical Trial — Europe PMC PMID:41231502

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41231502
DOI
10.1001/jamaoncol.2025.4721
License (as archived)
solo-consultazione
Archived
2026-11-07T03:56:04.204Z
SHA-256 of the archived text
736cda0e80236dfd4f3eea21f688a81c40c72e6ffda05b30a0688084dc6cafb5
Stable URL of this page
https://metraipolis.com/documento/dc_7e2506e83022

How to cite

Nivolumab and Ipilimumab in Advanced Mismatch Repair-Deficient/Microsatellite Instability-High Noncolorectal Cancers: A Nonrandomized Clinical Trial — Europe PMC PMID:41231502 — Europe PMC (en), https://europepmc.org/article/MED/41231502 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7e2506e83022 (Metraipolis archive dc_7e2506e83022, sha256 736cda0e80236dfd4f3eea21f688a81c40c72e6ffda05b30a0688084dc6cafb5)
BibTeX
@misc{dc7e2506e83022,
  title = {Nivolumab and Ipilimumab in Advanced Mismatch Repair-Deficient/Microsatellite Instability-High Noncolorectal Cancers: A Nonrandomized Clinical Trial — Europe PMC PMID:41231502},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41231502},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7e2506e83022; sha256 736cda0e80236dfd4f3eea21f688a81c40c72e6ffda05b30a0688084dc6cafb5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41231502. Agents can read the archived copy with the MCP tool read_document.